Bispecific antibodies tethering innate receptors induce human tolerant-dendritic cells and regulatory T cells

by Lucille Lamendour, Mäelle Gilotin, Nora Deluce-Kakwata Nkor, Zineb Lakhrif, Daniel Meley, Anne Poupon, Anne Poupon, Thibaut Laboute, Anne di Tommaso, Jean-Jacques Pin, Denis Mulleman, Denis Mulleman, Guillaume Le Mélédo, Guillaume Le Mélédo, Nicolas Aubrey, Hervé Watier, Florence Velge-Roussel
Published 2024-03-01

Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trials

by Philippe Goupille, Denis Mulleman, Jacqueline Detert, Theodora Bejan-Angoulvant, Johan Law-Wan, Marc-Antoine Sparfel, Sophie Derolez, Nicolas Azzopardi
Published 2021-12-01

Joint manifestations revealing inborn metabolic diseases in adults: a narrative review

by Amaury Loret, Claire Jacob, Saloua Mammou, Adrien Bigot, Hélène Blasco, Alexandra Audemard-Verger, Ida VD Schwartz, Denis Mulleman, François Maillot
Published 2023-08-01

Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis

by Stéphane Paul, Hubert Marotte, Arthur Kavanaugh, Philippe Goupille, Tore K. Kvien, Marc deLongueville, Denis Mulleman, William J. Sandborn, Niels Vande Casteele
Published 2020-07-01

Impact of Anti-Inflammatory Drugs on Pyogenic Vertebral Osteomyelitis: A Prospective Cohort Study

by Aurélien Dinh, Maxime Jean, Frédérique Bouchand, Benjamin Davido, Alexis Descatha, Clara Duran, Guillaume Gras, Christian Perronne, Denis Mulleman, Jérôme Salomon, Louis Bernard
Published 2016-01-01

Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment—A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model

by David Ternant, Olivier Le Tilly, Laurence Picon, Driffa Moussata, Christophe Passot, Theodora Bejan-Angoulvant, Céline Desvignes, Denis Mulleman, Philippe Goupille, Gilles Paintaud
Published 2021-11-01

Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider

by Astrid van Tubergen, Gertjan Wolbink, Alejandro Balsa, Victoria Navarro-Compán, Denis Mulleman, John Isaac, Meghna Jani, Borja Hernandez-Breijo, Johanna Elin Gehin, Charlotte Krieckaert, Guillaume le Mélédo
Published 2022-06-01

Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi s...

by Daniel Aletaha, Katerina Chatzidionysiou, Alfons A den Broeder, Paco M J Welsing, Rieke Alten, Bart van den Bemt, Denis Mulleman, James Galloway, John Isaac, P Verschueren, Arnold G Vulto, Céleste J T van der Togt, Lise Verhoef
Published 2023-03-01

Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study

by Eric Toussirot, Hubert Marotte, Denis Mulleman, Grégoire Cormier, Fabienne Coury, Philippe Gaudin, Emmanuelle Dernis, Christine Bonnet, Richard Damade, Jean-Luc Grauer, Tassadit Ait Abdesselam, Caroline Guillibert-Karras, Frédéric Lioté, Pascal Hilliquin, Antoinette Sacchi, Daniel Wendling, Benoît Le Goff, Marc Puyraveau, Gilles Dumoulin
Published 2020-09-01

Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial

by Grégoire Cormier, Benoit Le Goff, Emmanuelle Dernis, Philippe Goupille, Aleth Perdriger, Theo Rispens, David Ternant, Gilles Paintaud, Emilie Ducourau, Marine Samain, Fabienne Le Guilchard, Lucia Andras, Eric Lespessailles, Antoine Martin, Thomas Armingeat, Valérie Devauchelle-Pensec, Elisabeth Gervais, Annick de Vries, Eric Piver, Céline Desvignes, Hervé Watier, Denis Mulleman
Published 2020-05-01